These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17435103)

  • 1. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE; Willesen JL
    Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
    Huang HP; Lien YH
    Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a combination of imidacloprid and moxidectin against parasites of reptiles and rodents: case reports.
    Mehlhorn H; Schmahl G; Mevissen I
    Parasitol Res; 2005 Oct; 97 Suppl 1():S97-S101. PubMed ID: 16228282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Demodex gatoi with 10% Imidacloprid/1% Moxidectin.
    Short J; Gram D
    J Am Anim Hosp Assoc; 2016; 52(1):68-72. PubMed ID: 26606209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats.
    Fourie LJ; Kok DJ; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S112-3. PubMed ID: 12928871
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
    Fourie JJ; Meyer L; Thomas E
    Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris).
    Kim KR; Ahn KS; Oh DS; Shin SS
    Parasit Vectors; 2012 Aug; 5():158. PubMed ID: 22871121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
    Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
    Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
    Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin-compounded Feed Compared with Topical Moxidectin-Imidacloprid for Eradication of
    Nashat MA; Ricart Arbona RJ; Lepherd ML; Santagostino SF; Livingston RS; Riedel ER; Lipman NS
    J Am Assoc Lab Anim Sci; 2018 Sep; 57(5):483-497. PubMed ID: 30185284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.
    Han HS; Noli C; Cena T
    Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
    Bowman DD; Charles SD; Arther RG; Settje T
    Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.